Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells

被引:21
作者
Aoukaty, A
Lee, IF
Wu, J
Tan, RS
机构
[1] British Columbia Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC V6H 2V4, Canada
[2] Univ British Columbia, Vancouver, BC V6H 2V4, Canada
[3] British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 2V4, Canada
基金
加拿大健康研究院;
关键词
chronic active Epstein-Barr virus infection; natural killer cells;
D O I
10.1023/A:1022580929226
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic active Epstein-Barr virus (CAEBV) infection is an uncommon and severe manifestation of EBV infection that frequently leads to the development of natural killer (NK) or T cell lymphomas. We report here that NK cells derived from a boy with CAEBV showed decreased cytotoxic function and impaired interferon-gamma secretion against a variety of transformed target cell lines. In addition, NK cells from the patient lacked expression of the broadly expressed NK receptor, leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1). These data suggest that CAEBV is associated with low expression of LAIR-1 on NK cells.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 11 条
[1]   Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase [J].
Aoukaty, A ;
Tan, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :13331-13337
[2]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[3]   Ligands for natural killer cell receptors: redundancy or specificity [J].
Cerwenka, A ;
Lanier, LL .
IMMUNOLOGICAL REVIEWS, 2001, 181 :158-169
[4]   2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways [J].
Chuang, SS ;
Kumaresan, PR ;
Mathew, PA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6210-6216
[5]   Clinical and virologic characteristics of chronic active Epstein-Barr virus infection [J].
Kimura, H ;
Hoshino, Y ;
Kanegane, H ;
Tsuge, I ;
Okamura, T ;
Kawa, K ;
Morishima, T .
BLOOD, 2001, 98 (02) :280-286
[6]   LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes [J].
Meyaard, L ;
Adema, GJ ;
Chang, CW ;
Woollatt, E ;
Sutherland, GR ;
Lanier, LL ;
Phillips, JH .
IMMUNITY, 1997, 7 (02) :283-290
[7]  
Meyaard L, 1999, J IMMUNOL, V162, P5800
[8]   SEVERE CHRONIC ACTIVE EPSTEIN-BARR-VIRUS INFECTION SYNDROME [J].
OKANO, M ;
MATSUMOTO, S ;
OSATO, T ;
SAKIYAMA, Y ;
THIELE, GM ;
PURTILO, DT .
CLINICAL MICROBIOLOGY REVIEWS, 1991, 4 (01) :129-135
[9]   X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells [J].
Parolini, S ;
Bottino, C ;
Falco, M ;
Augugliaro, R ;
Giliani, S ;
Franceschini, R ;
Ochs, HD ;
Wolf, H ;
Bonnefoy, JY ;
Biassoni, R ;
Moretta, L ;
Notarangelo, LD ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :337-346
[10]   THE CHRONIC MONONUCLEOSIS SYNDROME [J].
STRAUS, SE .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) :405-412